Tergus Pharma and MedPharm are now one company!
The two premier topical experts have joined forces to create the world’s leading topical CDMO with global reach, experienced leadership, strong financial backing, and expanded end-to-end capabilities from early stage development through full commercial production of topical drug products.
Click here for the official press release.
MedPharm is a global Contract Development and Manufacturing Organization (CDMO) that provides topical and transdermal product design, development, and manufacturing services. We utilize our unique cost-effective performance testing models to mitigate risk and accelerate development times.
Accelerate your drug delivery project with us. We understand the challenges and opportunities found within the topical and transdermal industry, enabling us to cost-efficiently and rapidly deliver investable pharmaceutical products.
Our integrated approach to drug delivery provides a clear line of sight on any associated risks to ensure a seamless development process.
Discover moreHow we helped a leading pharma company ensure timely supply of clinical trial material
Wherever you are based, we are committed to adding short and long-term value to your company. We apply our unparalleled resources and consultative approach to create best-in-class solutions that enable you to reach your project’s milestones.
Discover moreIt is important to stay abreast of regulatory issues impacting this dynamic industry. Our deep understanding of the regulatory landscape and close relationships with the relevant authorities will help you to smoothly navigate the often-complex compliance processes.
Discover moreSupporting clients in getting multiple generic approvals using in vitro bioequivalence testing, avoiding risky and expensive clinical trials.
Discover moreSKIN
World-renowned experts in the design and testing of effective, safe and aesthetically elegant dermatological formulations for topical, local and transdermal drug delivery.
NAILS
Extensive expertise in the development of drugs for ungual and transungual drug delivery, including ownership of proprietary efficacy testing models.
EYE
Outstanding track record of developing drops, lotions and injectables covering conjunctival, corneal, intravitreal and transcleral routes of delivery.
AIRWAYS
Decades of experience developing and characterizing suitable drug products and devices for delivery to the nasal cavity and lung.
MUCOSAL MEMBRANES
Expertise in the development of an extensive range of dosage forms for vaginal, rectal and oromucosal drug delivery.
EAR
Specific drops, lotions and other topicals developed for treating outer and middle ear conditions.